Features
Latest World Pharmaceuticals Feature
Chain of command The pandemic has disrupted much of medical life and clinical trial supply chains are no exception. In part, this is a question of necessity. With lockdowns making traditional...
Lean medical writing: Story not storage The most difficult task an author can face is clearly summarising a complex and data-filled clinical regulatory document and explaining the data. Barry Drees, co-founder and...
Remote control Increased use of mobile apps in clinical trials promises interconnected ecosystems, faster studies, and access to continuous data – all at the touch of a button. But just how crucial...
Go to waste The supply slowdowns caused by the pandemic highlighted the importance of building redundancy and flexibility into the supply chain. A Herculean effort to keep clinical trials...
Virtual trial and error To withstand the disruption seen during Covid-19, clinical trials need to be responsive to the needs and abilities of all stakeholders. As more and more research moves out of the...
Improving diversity A growing awareness that different demographics experience disease and medication differently has prompted industry calls for clinical trials to better represent the population a drug...
A matter of time Without lipid nanoparticles, there’s no mRNA vaccine, no 95% efficacy, and the route out of the pandemic is many times longer and narrower. Tim Gunn speaks to Robert Langer, MIT...
Root and branch Pharmaceutical companies were setting ambitious deadlines for improving supply chain sustainability prior to Covid-19. The pandemic has since laid bare their reliance on complex chains...
War and IPs Like never before, the pharmaceutical supply chain is a geopolitical arena, but when every surge of the virus and variation in vaccine yield raises the stakes, familiar...
Pathway to excipients Innovation in drug development has continued at an often dizzying pace during the pandemic, but in the area of excipients, it’s hampered by a burdensome regulatory process. Kim...
Track and trace There’s nothing like a pandemic for demonstrating the necessity for serialisation, interoperability, and more advanced analytics and tracking. Tim Gunn asks Rob Handfield, the...
Close of play Given the lack of standardisation on shape, size and material for closed-system transfer devices (CSTDs), many pharmaceutical companies are struggling to ensure their products work...
4.0 lights the way It might sound like the latest software update for your iPhone, but Industry 4.0 is sending shockwaves through manufacturing industries. Mae Losasso speaks to Ian Cronin, project lead...
Life transport Intricate supply chains have been a part of medical life for decades – but nowhere are they more complex than in the field of cell and gene therapy. Many treatments are...
Twisted system If you wanted to devise a test for how well pharma has optimised its logistics, you couldn’t do much better than asking the industry to build the supply chains for Covid-19...
Travel risk It’s not just shifting portfolios and expanding markets that supply chain strategies need to take into account. Our understanding of what constitutes an effective cold chain...
Vial bodies The global Covax initiative aims to produce two billion doses of Covid-19 vaccines by 2021 – without building any new factories. That’s going to take a lot of flexible,...
Black swan theory Covid-19 has ruthlessly exposed pharmaceutical supply chain issues, raising one huge question for companies and governments across Europe and North America: is it time to...
Development from home There’s nothing like a global pandemic for driving interest in remote drug development – but can computer-aided biology change how drugs are designed in the long term, or is it just...
View all features A-Z
